Cornell University-医療機器分野:企業M&A・提携分析

◆英語タイトル:Cornell University - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012955
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cornell University (CU) is an educational institute that offers graduate and undergraduate education and research services. The institute offers education in biological and environmental engineering, communication, crop and soil sciences, development sociology, biological statistics and computational biology, animal science, applied economics and management, earth and atmospheric sciences, ecology and evolutionary biology, molecular biology and genetics, natural resources, neurobiology and behavior, and nutritional sciences. It offers research in the fields of sciences and humanities. The institute operates in the US, Qatar, and Italy. CU is headquartered in Ithaca, New York, the US.

Cornell University – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cornell University, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Cornell University, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Cornell University, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Cornell University, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Cornell University, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Cornell University, Medical Equipment, Deal Details 10
Partnerships 10
OncoCyte Enters into Licensing Agreement with Cornell University for PanC-Dx 10
Empire Genomics Enters Into Licensing Agreement With Cornell University For Genomic Biomarker 11
Prolias Technologies Enters Into Licensing Agreement With Cornell University For microRNA Diagnostic Portfolio 12
Cornell University – Key Competitors 13
Cornell University – Key Employees 14
Cornell University – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Product News 16
Feb 06, 2017: Cornell Tech: First Smartphone Study Launches to Examine Impulse Control 16
May 05, 2016: Rapid, Low-Cost Detection of Zika Virus Developed by Experts at U of T, Harvard, MIT, Cornell and more 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Cornell University, Medical Equipment, Key Facts 2
Cornell University, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Cornell University, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Cornell University, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Cornell University, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Cornell University, Deals By Market, 2011 to YTD 2017 8
Cornell University, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
OncoCyte Enters into Licensing Agreement with Cornell University for PanC-Dx 10
Empire Genomics Enters Into Licensing Agreement With Cornell University For Genomic Biomarker 11
Prolias Technologies Enters Into Licensing Agreement With Cornell University For microRNA Diagnostic Portfolio 12
Cornell University, Key Competitors 13
Cornell University, Key Employees 14
Cornell University, Subsidiaries 15

★海外企業調査レポート[Cornell University-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Samsung Biologics Co Ltd (207940):製薬・医療:M&Aディール及び事業提携情報
    Summary Samsung Biologics Co Ltd (Samsung Biologics) is a biologics development and manufacturing company. The company’s business activities include process development, contract manufacturing, aseptic fill and finish and project management. Samsung Biologics cell culture development process include …
  • Kronos Worldwide Inc (KRO):企業の財務・戦略的SWOT分析
    Kronos Worldwide Inc (KRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Jiangsu Kanion Pharmaceutical Co Ltd (600557):製薬・医療:M&Aディール及び事業提携情報
    Summary Jiangsu Kanion Pharmaceutical Co Ltd (Jiangsu Kanion) is a developer, producer and marketer of concentrated drugs. The company offers products in the therapeutic areas of orthopedics, cardiovascular, gynecology, antitumor, anti-infective, and others. It also offers products for fever, headac …
  • Trevena Inc (TRVN):企業の財務・戦略的SWOT分析
    Summary Trevena Inc (Trevena) is a biotechnology company that discovers and develops G-protein coupled receptor targeted medicines. The company provides products such as RV027, TRV130, TRV734 and TRV250. Its TRV027 is an intravenous drug used for the treatment of acute heart failure in combination w …
  • California Water Service Group (CWT):企業の財務・戦略的SWOT分析
    Summary California Water Service Group (California Water Service) is a utility service provider that offers wastewater services and water operation and maintenance services. The utility provides services such as water and wastewater utility services, and operating water and wastewater systems servic …
  • Split Rock Partners, LLC:企業の戦略・SWOT・財務情報
    Split Rock Partners, LLC - Strategy, SWOT and Corporate Finance Report Summary Split Rock Partners, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Plexus Corp (PLXS):企業の財務・戦略的SWOT分析
    Plexus Corp (PLXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • China Communications Construction Co Ltd:企業の戦略・SWOT・財務情報
    China Communications Construction Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Communications Construction Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Technology Nexus AB:企業の戦略的SWOT分析
    Technology Nexus AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Wells Fargo Private Bank:企業の戦略・SWOT・財務情報
    Wells Fargo Private Bank - Strategy, SWOT and Corporate Finance Report Summary Wells Fargo Private Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • SRS Medical Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary SRS Medical Systems Inc (SRS Medical) is a medical device company that designs, manufactures and markets diagnostics and disposable products. The company offers spanner, test systems, urodynamic systems, uroflows, uroscan bladder ultrasound systems and disposables. Its disposables products c …
  • Chesnara plc:企業の戦略・SWOT・財務情報
    Chesnara plc - Strategy, SWOT and Corporate Finance Report Summary Chesnara plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Engie SA (ENGI):企業の財務・戦略的SWOT分析
    Engie SA (ENGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Faiveley Transport SA:企業の戦略的SWOT分析
    Faiveley Transport SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • NPO Petrovax Pharm LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary NPO Petrovax Pharm LLC (Petrovax) focuses on the research, development and manufacturing of medicines and vaccines. The company’s expertise spans in producing APIs and liquid, semi-solid, and solid dosage forms in ampoules, plastic containers, vials and disposable syringes. It also provides …
  • Genpact Ltd:企業の戦略・SWOT・財務情報
    Genpact Ltd - Strategy, SWOT and Corporate Finance Report Summary Genpact Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Bush Industries Inc
    Bush Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Bush Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Tecan Group Ltd (TECN)-医療機器分野:企業M&A・提携分析
    Summary Tecan Group Ltd (Tecan) is a provider of automated laboratory instruments and solutions for use in basic and translational research, clinical diagnostics, and drug discovery. The company develops, manufactures, and markets automated workflow solutions for laboratories and instrumentation sup …
  • Dil Ltd (506414):企業の財務・戦略的SWOT分析
    Summary Dil Ltd (Dil), formerly Duphar-Interfran Ltd, is a developer of medicinal and pharmaceutical products. The company offers products in the areas such as biotechnology, environmental solutions, pharmaceuticals, and vitamins. It also offers services such as health and wellness, entertainment, e …
  • Viridian Group Investments Ltd:企業の戦略的SWOT分析
    Viridian Group Investments Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆